跳转至内容
Merck
CN

203729

Brefeldin A

Specifically and reversibly blocks translocation of proteins from the endoplasmic reticulum (ER) to the Golgi apparatus without affecting endocytosis or lysosome function.

别名:

(+)-Brefeldin A，来源于布雷正青霉菌, 1,6,7,8,9,11a,12,13,14,14a-十氢-1,13-二羟基-6-甲基-4H-环戊[f]氧杂环十三烷-4-酮（布雷非德菌素 A）

登录 查看组织和合同定价。

选择尺寸

关于此项目

经验公式（希尔记法）:
C16H24O4
化学文摘社编号:
20350-15-6
分子量:
280.36
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
MFCD12913297

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

(+)-Brefeldin A，来源于布雷正青霉菌, Specifically and reversibly blocks translocation of proteins from the endoplasmic reticulum (ER) to the Golgi apparatus without affecting endocytosis or lysosome function.

SMILES string

O1[C@H](CCC\C=C\[C@H]2[C@H]([C@H](\C=C\C1=O)O)C[C@H](C2)O)C

InChI

1S/C16H24O4/c1-11-5-3-2-4-6-12-9-13(17)10-14(12)15(18)7-8-16(19)20-11/h4,6-8,11-15,17-18H,2-3,5,9-10H2,1H3/b6-4+,8-7+/t11-,12+,13-,14+,15-/m0/s1

InChI key

KQNZDYYTLMIZCT-PNFJWZTBSA-N

description

Merck USA index - 14, 1369

assay

≥95% (HPLC)

form

crystalline solid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze

color

white

solubility

methanol: 2 mg/mL

shipped in

ambient

storage temp.

−20°C

Quality Level

100

正在寻找类似产品? 访问 产品对比指南

相关类别

General description

特异且可逆地阻断蛋白质从内质网（ER）向高尔基体转运，而不影响内吞或溶酶体功能。HDL介导的胆固醇外流的抑制剂。<40 ng/ml. Blocks binding of ADP-ribosylation factor to the Golgi and inhibits the GDP-GTP exchange. Inhibits the activity of BIG1 and BIG2, the guanine-nucleotide exchange proteins for ADP-ribosylation factors. Also available as a 25 mM solution in DMSO (Cat. No. 500583可导致多种哺乳动物细胞中的高尔基体解体和ER肿胀。

Biochem/physiol Actions

主要目的
阻断蛋白质从内质网（ER）向高尔基体转运
产品不与ATP竞争。
可逆性：是
细胞渗透性：否

Preparation Note

溶解后，等分并冷冻保存（-20°C）。储备溶液在-20°C下可稳定保存2个月。

Other Notes

Yamagi, R., et al. 2000.Proc.Natl.Acad.Sci. USA 97, 2567.
Moriango, N., et al. 1996.Proc.Natl.Acad.Sci. USA 93, 12856.
Mendez, A.J.1995.J. Biol. Chem. 270, 5891.
Ridgway, N.D., et al. 1995.J. Biol. Chem. 270, 8023.
Tsai, S.C., et al. 1994.Proc.Natl.Acad.Sci. USA91, 3063.
Ktistakis, N.Y., et al. 1992.Nature356, 344.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

毒性：有害（C）

pictograms

Skull and crossbones
GHS06

signalword

Danger

hcodes

H301

Hazard Classifications

Acute Tox. 3 Oral

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Tonke K Raaijmakers et al.
Journal for immunotherapy of cancer, 8(1) (2020-05-29)
Tumor ablation techniques, like cryoablation, are successfully used in the clinic to treat tumors. The tumor debris remaining in situ after ablation is a major antigen depot, including neoantigens, which are presented by dendritic cells (DCs) in the draining lymph
Daniela Cunha et al.
Cells, 13(11) (2024-06-19)
Basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) are high-incidence, non-melanoma skin cancers (NMSCs). The success of immune-targeted therapies in advanced NMSCs led us to anticipate that NMSCs harbored significant populations of tumor-infiltrating lymphocytes with potential anti-tumor activity. The
Yan Lin et al.
Journal of immunology research, 2021, 8899674-8899674 (2021-01-26)
Tuberculosis is the world's most deadly infectious disease, with 10 million people falling ill and 1.5 million people dying from the disease every year. With the increasing number of drug-resistant Mycobacterium tuberculosis (MTB) strains and prevalence of coinfection of MTB
Kai Bartkowiak et al.
Cancers, 13(3) (2021-02-06)
(1) Background: the early detection of cancer cells in the blood or bone marrow of breast cancer patients improves the understanding of metastasis. Disseminating tumor cells in the bone marrow with a pronounced manifestation of mesenchymal markers (mDTC) are difficult
Shreyasi Maity et al.
Infection and immunity, 91(10), e0026723-e0026723 (2023-09-19)
In view of the antagonism of Wnt5A signaling toward microbial pathogens, we were interested in evaluating the therapeutic potential of recombinant Wnt5A (rWnt5A) in curbing Leishmania donovani infection. Initially, using L. donovani-infected RAW 264.7 and peritoneal macrophages, we demonstrated that
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持